I also loved this one.
WCK 5222 has been used successfully for a US patient!
Cleared out a nasty infection of metallo-β-lactamase-harbouring P aeruginosa in a young cancer patient, who was administered the drug on compassionate grounds, since there were no other treatment options left. 4 weeks, all clear, and well tolerated.
Feel proud that an Indian company has innovated like this.
Disclosure: Invested from lower levels, this is one of my investments “from the heart” (though I know one should never do this, what’s the fun if you don’t listen to your heart?)
| Subscribe To Our Free Newsletter |
